{"title":"Antidepressant prescribing inequalities in people with comorbid depression and type 2 diabetes: A UK primary care electronic health record study.","authors":"Yutung Ng, Joseph F Hayes, Annie Jeffery","doi":"10.1371/journal.pone.0309153","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To compare the likelihood of being prescribed an antidepressant in depressed individuals with and without type 2 diabetes.</p><p><strong>Methods: </strong>We performed a matched cohort study using primary care record data from the UK Clinical Practice Research Datalink. We used multivariable logistic regression to compare antidepressant prescribing during the first five years of starting oral antidiabetic medication to a comparison group without type 2 diabetes, matched based on GP practice, age and sex. We performed subgroup analyses stratified by sex, age and ethnicity.</p><p><strong>Results: </strong>People with type 2 diabetes and depression were 75% less likely to be prescribed an antidepressant compared to people with depression alone (odds ratio (OR) 0.25, 95% confidence interval (CI) 0.25 to 0.26). This difference was greater in males (OR 0.23, 95% CI, 0.22 to 0.24), people older than 56 years (OR 0.23, 95% CI, 0.22 to 0.24), or from a minoritised ethnic background (Asian OR 0.14, 95% CI 0.12-0.14; Black OR 0.12, 95% CI 0.09-0.14).</p><p><strong>Conclusions: </strong>There may be inequalities in access to antidepressant treatment for people with type 2 diabetes, particularly those who are male, older or from minoritised ethnic backgrounds.</p>","PeriodicalId":20189,"journal":{"name":"PLoS ONE","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537397/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS ONE","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1371/journal.pone.0309153","RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To compare the likelihood of being prescribed an antidepressant in depressed individuals with and without type 2 diabetes.
Methods: We performed a matched cohort study using primary care record data from the UK Clinical Practice Research Datalink. We used multivariable logistic regression to compare antidepressant prescribing during the first five years of starting oral antidiabetic medication to a comparison group without type 2 diabetes, matched based on GP practice, age and sex. We performed subgroup analyses stratified by sex, age and ethnicity.
Results: People with type 2 diabetes and depression were 75% less likely to be prescribed an antidepressant compared to people with depression alone (odds ratio (OR) 0.25, 95% confidence interval (CI) 0.25 to 0.26). This difference was greater in males (OR 0.23, 95% CI, 0.22 to 0.24), people older than 56 years (OR 0.23, 95% CI, 0.22 to 0.24), or from a minoritised ethnic background (Asian OR 0.14, 95% CI 0.12-0.14; Black OR 0.12, 95% CI 0.09-0.14).
Conclusions: There may be inequalities in access to antidepressant treatment for people with type 2 diabetes, particularly those who are male, older or from minoritised ethnic backgrounds.
目的:比较患有和未患有 2 型糖尿病的抑郁症患者被处方抗抑郁药的可能性:我们利用英国临床实践研究数据链(UK Clinical Practice Research Datalink)中的初级保健记录数据进行了一项匹配队列研究。我们使用多变量逻辑回归法,比较了在开始口服抗糖尿病药物的头五年中,抗抑郁药处方的开具情况,并与根据全科医生诊所、年龄和性别进行匹配的无 2 型糖尿病的对比组进行了比较。我们按性别、年龄和种族进行了分组分析:与仅患有抑郁症的患者相比,2型糖尿病合并抑郁症患者获得抗抑郁药物处方的几率要低75%(几率比(OR)为0.25,95%置信区间(CI)为0.25至0.26)。这一差异在男性(OR 0.23,95% CI,0.22-0.24)、56 岁以上(OR 0.23,95% CI,0.22-0.24)或来自少数族裔背景(亚裔 OR 0.14,95% CI 0.12-0.14;黑人 OR 0.12,95% CI 0.09-0.14)的人群中更大:结论:2型糖尿病患者在接受抗抑郁治疗方面可能存在不平等现象,尤其是男性、老年人或来自少数民族背景的患者。
期刊介绍:
PLOS ONE is an international, peer-reviewed, open-access, online publication. PLOS ONE welcomes reports on primary research from any scientific discipline. It provides:
* Open-access—freely accessible online, authors retain copyright
* Fast publication times
* Peer review by expert, practicing researchers
* Post-publication tools to indicate quality and impact
* Community-based dialogue on articles
* Worldwide media coverage